Concepedia

Vivien Low

VL

9

Publications

830

Citations

9

H-Index

2014

Active since

Affiliations

Weill Cornell Medicine(Current)

Cornell University

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

Beth Israel Deaconess Medical Center

Vivien Low is an author at Weill Cornell Medicine specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2023

9

Publications

9

Age-induced accumulation of methylmalonic acid promotes tumour progression

Ana P. Gomes, Didem Ilter, Vivien Low et al. · Nature · 2020 · 238 citations · Full text

Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes

Raffaella Di Micco, Bárbara Fontanals-Cirera, Vivien Low et al. · Cell Reports · 2014 · 212 citations · Full text

Altered propionate metabolism contributes to tumour progression and aggressiveness

Ana P. Gomes, Didem Ilter, Vivien Low et al. · Nature Metabolism · 2022 · 101 citations · Full text

, , +6

Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization

Ana P. Gomes, Didem Ilter, Vivien Low et al. · Cancer Cell · 2019 · 97 citations · Full text

, , +14

Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression

Zhongchi Li, Vivien Low, Valbona Luga et al. · Nature Communications · 2022 · 59 citations · Full text

Rows per page

1–5 of 9